New Enterprise Associates 14, L.P. 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-09 4:32 pm Sale |
2023-01-03 | 13D | Oyster Point Pharma, Inc. OYST |
New Enterprise Associates 14, L.P. | 0 0.000% |
-5,925,287 (Position Closed) |
Filing |
| 2022-11-21 1:29 pm Unchanged |
2022-11-07 | 13D | Oyster Point Pharma, Inc. OYST |
New Enterprise Associates 14, L.P. | 5,925,287 22.100% |
0 (Unchanged) |
Filing |